A New Standard in Communication

Binary Code making up image that says Big Data
Raja Mazumder, PhD, professor of biochemistry and molecular medicine

A consortium led by researchers from the George Washington University (GW) received a $2.2 million, five-year renewal of a grant from the U.S. Food and Drug Administration (FDA) for their BioCompute Object Specification Project. The venture, which began in 2017, is working to establish standards for communicating high-throughput sequencing (HTS) computations and data analysis, known as BioCompute Objects (BCOs).

“In order to help drive personalized medicine we need to find a better way to compare and build on genomic data that could yield insights into cancer, ancestry, microbiome dynamics, metagenomics, and more,” said principal investigator Raja Mazumder, PhD, professor of biochemistry and molecular medicine at the GW School of Medicine and Health Sciences. “This is where the BioCompute Object Specification Project comes in.”

The research team gathered feedback on the effort to streamline data and workflow exchange between the FDA, researchers, pharmaceutical companies, and bioinformatics technology developers through a series of industry workshops. Results of those meetings were published in two BCO specification documents – one in 2017 and another updated document in 2018. It was officially recognized as a standard by the Institute of Electrical and Electronics Engineers Standards Association.

Because establishing and maintaining HTS standards for validating data, computation, and interoperability is critical to the FDA’s regulatory mission, the consortium aims to create an accompanying database (BioComputeDB). The database will include development of mechanisms to transfer BCOs, updates to the technical specification documentation, and host regular informational sessions for FDA personnel on the creation and use of BCOs. 
 

Latest News

The George Washington University (GW) Medical Faculty Associates (MFA) is extending its reach in suburban communities, expanding primary care services and bringing convenient, high-quality, and comprehensive health care to Northern Virginia, suburban Maryland, and the Washington, D.C., metropolitan…
Medicine is slowly evolving into a multimedia arena, one that melds in-person visits with technology-based care. This shift has been convenient and cost-effective for both patients and doctors, but it also has opened an avenue to care for a specific patient population: the elderly.
The George Washington University School of Medicine and Health Sciences, under the leadership of Maranda C. Ward, EdD ’17, has been awarded a pair of grants totaling more than $816,000 from Gilead Sciences Inc., in support of an 18-month research-informed educational initiative, Two in One: HIV+…